Stock NKGN NKGEN BIOTECH, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NKGen Biotech, Inc.

Equities

NKGN

US65488A1016

Real-time Estimate Cboe BZX
Other stock markets
 15:47:22 03/07/2024 BST 		5-day change 1st Jan Change
1.275 USD +5.37% Intraday chart for NKGen Biotech, Inc. +1.68% -56.00%
06-18 NKGen Biotech, Inc. announced that it has received $0.8 million in funding from AJB Capital Investments LLC, Sandia Investment Managment LP, Diametric Capital, LP CI
06-12 NKGen Biotech, Inc. Presents Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy for Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NKGEN BIOTECH, INC. Stock NKGen Biotech, Inc.
 30.11M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 44.87B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 37.8B
LONZA GROUP AG Stock Lonza Group AG
 37.61B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 31.32B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.4B
  1. Stock Market
  2. Equities
  3. NKGN Stock
  4. Charts NKGen Biotech, Inc.
  5. Sector Chart